Real-world evidence from a retrospective study on suicide during depression: clinical characteristics, treatment patterns and disease burden

  • 0Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, National Clinical Research Center for Mental Disorders & National Center for Mental Disorders, Capital Medical University, 5 Ankang Hutong Road, Xicheng District, 100088, Beijing, China.

|

|

Summary

This summary is machine-generated.

Major depressive disorder (MDD) patients with suicidal ideation or behavior are younger, female, and experience more stress. They show higher re-hospitalization rates and complex treatment needs, including combined therapies.

Area Of Science

  • Neuroscience
  • Psychiatry
  • Clinical Medicine

Background

  • Major depressive disorder (MDD) is a significant mental health condition where suicide is a primary symptom and severe outcome.
  • Effective treatment strategies for MDD patients experiencing suicidal ideation or behavior are scarce, necessitating further research into disease characteristics and therapeutic approaches.

Purpose Of The Study

  • To investigate the distinct demographic and clinical characteristics of MDD patients with suicidal ideation or behavior (MDS) compared to those without (MDNS).
  • To analyze and compare treatment patterns, disease burden, and re-hospitalization rates between MDS and MDNS groups.

Main Methods

  • A retrospective study utilizing Electronic Health Records (EHR) from Beijing Anding Hospital (2013-2020).
  • Inclusion of 4138 MDD patients with suicidal ideation or behavior (MDS) and 3848 MDD patients without (MDNS).
  • Extraction and comparison of demographic data, clinical attributes, treatment approaches, disease burden, and re-hospitalization rates.

Main Results

  • MDS patients were younger, predominantly female, with earlier onset, higher alcohol consumption, and more frequent life stress events.
  • MDS group showed significantly higher re-hospitalization rates within six months post-discharge (11.36% vs. 8.91%).
  • MDS patients more frequently received combined electroconvulsive therapy (56.72% vs. 43.71%) and exhibited complex medication management, often involving antidepressants, antipsychotics, and mood stabilizers.

Conclusions

  • MDD patients with suicidal ideation or behavior present unique demographic and clinical profiles.
  • These patients face a greater illness burden and an increased risk of relapse, underscoring the need for tailored treatment strategies.
  • Intricate treatment patterns, including polypharmacy and combined therapies, are common in managing this patient subgroup.

Related Concept Videos

Depressive Disorders: Etiology 01:27

78

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...

Depression: Overview 01:18

242

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...

Depressive Disorders: MDD and Dysthymia 01:27

112

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...

Antidepressant Drugs: MAOIs and Other Agents 01:23

227

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Diagnostic and Statistical Manual of Mental Disorders (DSM) 01:27

55

The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...

Introduction to Epidemiology 01:26

723

Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...